Genzyme Oncology · Cambridge, MA United States
Company Description
View Genzyme Oncology Locations On A US Map
This link will open in a new window
This link will open in a new window Genzyme Oncology, a division of Genzyme , develops, manufactures, and markets traditional and gene-based cancer therapies. Its technology approaches include antiangiogenesis, which halts the growth of blood vessels in tumors; cancer diagnostics and vaccines; and a program attacking cancer at the cellular level. Marketed products include Campath (for the treatment of B-cell chronic lymphocytic leukemia, also known as B-CLL) and and the newly-approved Clolar, which is used in the treatment of relapsed acute lymphoblastic leukemia in children. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Genzyme Oncology Financials
| Company Type | |
| Sales (mil.) | $0.8 |
Genzyme Oncology Executives
7 executives listed for Genzyme Oncology's Cambridge, MA location.
| Title | Name & Bio | Contact |
| President and CEO | Henri Termeer | Network |
| SVP and Product General Manager | Terry Murdock | Network |
| SVP, Research and Development | Katherine Klinger | Network |
Competition
Competitive Landscape for Genzyme Oncology
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Genzyme Oncology Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!